Hellenic Society of Gastroenterology Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2018
NCT03592069
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Hellenic Society of Gastroenterology

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Digestive System Diseases (Phase 4)

Gastritis (Phase 4)

Gastrointestinal Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 4